Journal
PATHOLOGY RESEARCH AND PRACTICE
Volume 215, Issue 7, Pages -Publisher
ELSEVIER GMBH
DOI: 10.1016/j.prp.2019.152446
Keywords
MAGE-A11; ESCC; SP1, TFCP2, ZEB1; Expression; Prognosis
Categories
Funding
- Natural Science Foundation of Hebei Province, China [H2016206410]
- Financial Supporting Program of Hebei Province [[2014]1257]
- Financial department of Hebei Province [361006]
Ask authors/readers for more resources
Objective: To evaluate the clinical characteristics and prognostic significance of MAGE-A11 and transcription factors (SP1, TFCP2 and ZEB1) in patients with esophageal squamous cell carcinoma (ESCC). Methods: To assess the expression of MAGE-A11 and transcription factors (SP1, TFCP2 and ZEB1) in 121 ESCC samples were respectively detected by immunohistochemical method. Results: The results showed MAGE-All and transcription factors (SP1,TFCP2 and ZEB1) expression were associated with some clinical features in patients, such as pathological differentiation, tumor size, clinical stage, lymph node metastasis and distant metastasis. Kaplan-Meier analysis showed that patients with ESCC having high MAGE-All and transcription factors (SP1,TFCP2 and ZEB1) expression had a worse prognosis compared to the patients with low expression. Multivariate Cox proportional hazards regression model revealed that MAGE-A11 expression, TFCP2 expression, lymph node metastasis and distant metastasis were independently associated with ESCC patients' survival. Conclusions: High expression of MAGE-A11 and transcription factors (SP1,TFCP2 and ZEB1) in ESCC tissues suggests promoting ESCC progression and poor prognosis, co-expression of MAGE-All and transcription factors even worse.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available